• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经呼吸道感染甲型流感病毒的小鼠中的交叉保护作用与局部IgA抗体相关,而非血清抗体或细胞毒性T细胞反应性。

Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity.

作者信息

Liew F Y, Russell S M, Appleyard G, Brand C M, Beale J

出版信息

Eur J Immunol. 1984 Apr;14(4):350-6. doi: 10.1002/eji.1830140414.

DOI:10.1002/eji.1830140414
PMID:6609824
Abstract

Mice previously infected with an aerosol of A/Rec 31 influenza virus were strongly protected against an aerosol challenge with A/Vic influenza as judged by lung virus titers recovered 2 days after the challenge infection. Such complete homotypic immunity was not achieved by priming with live Rec 31 virus injected i.v. or UV-inactivated Rec 31 virus administered s.c. together with Al(OH)3 and saponin. The reason for the superior protective effect of the natural infection was investigated. The protection induced by respiratory infection with Rec 31 virus was specific for influenza A viruses. It was not correlated with specific serum hemagglutination inhibition antibody titer or cross-reactive cytotoxic T (Tc) cell reactivity. Moreover, the transfer of splenic and lymphoid T cell populations with strong secondary Tc activity did not significantly reduce lung virus titers in recipient mice 3 days after infection. The protection however occurred in parallel with the presence of cross-reactive IgA antibody in the lung washings. It thus appears that local secretory IgA plays a causal role in the prevention of cross-infection by influenza A virus. Serum antibody and Tc cells, on the other hand, may be crucial for recovery from such infection. All mice primed with live Rec 31 virus, administered i.v. or by aerosol and expressing equally high levels of Tc reactivity, survived a lethal challenge with A/PR8 virus. The same challenge, however, killed half of the mice immunized s.c. with inactivated Rec 31 virus which induced only a low level of Tc reactivity.

摘要

根据感染后2天回收的肺病毒滴度判断,先前感染过A/Rec 31流感病毒气溶胶的小鼠对A/Vic流感病毒气溶胶攻击具有强烈的保护作用。通过静脉注射活的Rec 31病毒或皮下注射与氢氧化铝和皂苷一起使用的紫外线灭活Rec 31病毒进行免疫,并未实现这种完全的同型免疫。对自然感染具有更强保护作用的原因进行了研究。Rec 31病毒呼吸道感染诱导的保护作用对甲型流感病毒具有特异性。它与特异性血清血凝抑制抗体滴度或交叉反应性细胞毒性T(Tc)细胞反应性无关。此外,具有强烈二次Tc活性的脾和淋巴T细胞群体的转移在感染后3天并未显著降低受体小鼠的肺病毒滴度。然而,这种保护作用与肺灌洗液中存在交叉反应性IgA抗体同时出现。因此,局部分泌型IgA似乎在预防甲型流感病毒交叉感染中起因果作用。另一方面,血清抗体和Tc细胞可能对从这种感染中恢复至关重要。所有用活的Rec 31病毒进行免疫的小鼠,通过静脉注射或气溶胶给药并表达同样高水平的Tc反应性,在接受A/PR8病毒的致死性攻击后存活下来。然而,同样的攻击杀死了一半用灭活Rec 31病毒皮下免疫的小鼠,这种病毒仅诱导了低水平的Tc反应性。

相似文献

1
Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity.经呼吸道感染甲型流感病毒的小鼠中的交叉保护作用与局部IgA抗体相关,而非血清抗体或细胞毒性T细胞反应性。
Eur J Immunol. 1984 Apr;14(4):350-6. doi: 10.1002/eji.1830140414.
2
Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules.通过被动转移针对不同血凝素分子的呼吸道IgA抗体对甲型流感病毒感染的交叉保护作用。
Eur J Immunol. 1991 Jun;21(6):1337-44. doi: 10.1002/eji.1830210602.
3
Protection and recovery in influenza virus-infected mice immunosuppressed with anti-IgM.用抗IgM免疫抑制的流感病毒感染小鼠的保护与恢复
J Immunol. 1985 Feb;134(2):1230-5.
4
Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, beta2-microglobulin-deficient, and J chain-deficient mice.在免疫功能完全正常、T细胞耗竭、β2-微球蛋白缺陷和J链缺陷小鼠中对致死性甲型流感病毒感染的异源亚型免疫机制。
J Immunol. 1997 Feb 1;158(3):1222-30.
5
Assessment of resistance to influenza virus infection in animal models.动物模型中流感病毒感染抗性的评估。
Dev Biol Stand. 1975;28:307-18.
6
TH cells primed during influenza virus infection provide help for qualitatively distinct antibody responses to subsequent immunization.在流感病毒感染期间启动的辅助性T细胞为后续免疫接种时性质不同的抗体反应提供帮助。
J Immunol. 1999 Nov 1;163(9):4673-82.
7
Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells.在缺乏I类限制性细胞毒性T细胞的情况下,小鼠可以从肺部流感病毒感染中恢复。
J Immunol. 1992 Jan 1;148(1):212-7.
8
Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.合成双链RNA聚肌苷酸胞嘧啶核苷酸(poly(I:C))与黏膜疫苗联合使用可预防流感病毒感染。
J Virol. 2005 Mar;79(5):2910-9. doi: 10.1128/JVI.79.5.2910-2919.2005.
9
Defense mechanisms against influenza virus infection in the respiratory tract mucosa.呼吸道黏膜针对流感病毒感染的防御机制。
Jpn J Infect Dis. 2004 Dec;57(6):236-47.
10
Protection against lethal influenza virus encephalitis by intranasally primed CD8+ memory T cells.经鼻启动的CD8 +记忆性T细胞对致死性流感病毒脑炎的保护作用。
J Immunol. 1996 Oct 1;157(7):3065-73.

引用本文的文献

1
Safety and Immunogenicity of aerosolized adenovirus-vectored COVID-19 vaccine and intramuscular mRNA vaccine bivalent boosters: a randomized open-label clinical trial.雾化腺病毒载体新冠疫苗和肌肉注射mRNA疫苗二价加强针的安全性和免疫原性:一项随机开放标签临床试验。
Nat Commun. 2025 Aug 7;16(1):7281. doi: 10.1038/s41467-025-62698-7.
2
A mouse protozoan boosts antigen-specific mucosal IgA responses in a specific lipid metabolism- and signaling-dependent manner.一种鼠源原生动物以特定脂质代谢和信号依赖的方式增强抗原特异性黏膜 IgA 应答。
Nat Commun. 2024 Sep 10;15(1):7914. doi: 10.1038/s41467-024-52336-z.
3
A Longitudinal Study in Tunisia to Assess the Anti-RBD IgG and IgA Responses Induced by Three Different COVID-19 Vaccine Platforms.
突尼斯的一项纵向研究,以评估三种不同新冠疫苗平台诱导的抗受体结合域免疫球蛋白G和免疫球蛋白A反应。
Trop Med Infect Dis. 2024 Mar 13;9(3):61. doi: 10.3390/tropicalmed9030061.
4
Changes in nasal, pharyngeal and salivary secretory IgA levels in patients with COVID-19 and the possibility of correction of their secretion using combined intranasal and oral administration of a pharmaceutical containing antigens of opportunistic microorganisms.新型冠状病毒肺炎患者鼻腔、咽部和唾液分泌型IgA水平的变化以及通过鼻内和口服联合给予含有机会性微生物抗原的药物来纠正其分泌的可能性。
Drugs Context. 2023 Jun 12;12. doi: 10.7573/dic.2022-10-4. eCollection 2023.
5
Promises and challenges of mucosal COVID-19 vaccines.黏膜 COVID-19 疫苗的前景与挑战。
Vaccine. 2023 Jun 19;41(27):4042-4049. doi: 10.1016/j.vaccine.2023.04.013. Epub 2023 Apr 10.
6
A Dual Adjuvant System for Intranasal Boosting of Local and Systemic Immunity for Influenza Vaccination.一种用于鼻内加强流感疫苗接种的局部和全身免疫的双重佐剂系统。
Vaccines (Basel). 2022 Oct 11;10(10):1694. doi: 10.3390/vaccines10101694.
7
Vaccine Type-, Age- and Past Infection-Dependence of the Humoral Response to SARS-CoV-2 Spike S Protein.疫苗类型、年龄和既往感染对 SARS-CoV-2 刺突 S 蛋白体液反应的依赖性。
Front Immunol. 2022 Feb 28;13:809285. doi: 10.3389/fimmu.2022.809285. eCollection 2022.
8
Serological assessment of SARS-CoV-2 infection during the first wave of the pandemic in Louisville Kentucky.肯塔基州路易斯维尔市大流行第一波期间 SARS-CoV-2 感染的血清学评估。
Sci Rep. 2021 Sep 14;11(1):18285. doi: 10.1038/s41598-021-97423-z.
9
Modified-Live Feline Calicivirus Vaccination Reduces Viral RNA Loads, Duration of RNAemia, and the Severity of Clinical Signs after Heterologous Feline Calicivirus Challenge.改良型活猫杯状病毒疫苗接种可降低异源猫杯状病毒攻毒后病毒 RNA 载量、RNA 血症持续时间和临床症状严重程度。
Viruses. 2021 Jul 30;13(8):1505. doi: 10.3390/v13081505.
10
Oral Bacteria Combined with an Intranasal Vaccine Protect from Influenza A Virus and SARS-CoV-2 Infection.口腔细菌与鼻腔疫苗联合使用可预防甲型流感病毒和 SARS-CoV-2 感染。
mBio. 2021 Aug 31;12(4):e0159821. doi: 10.1128/mBio.01598-21. Epub 2021 Aug 17.